Mesoprefrontal dopaminergic neurons: can tyrosine availability influence their functions?

[1]  A. Diamond,et al.  Impaired sensitivity to visual contrast in children treated early and continuously for phenylketonuria. , 1996, Brain : a journal of neurology.

[2]  Daniel R Weinberger,et al.  On the Plausibility of “The Neurodevelopmental Hypothesis” of Schizophrenia , 1996, Neuropsychopharmacology.

[3]  P S Goldman-Rakic,et al.  Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Roth,et al.  Tyrosine enhances behavioral and mesocorticolimbic dopaminergic responses to aversive conditioning , 1996, Synapse.

[5]  L. D. de Sonneville,et al.  Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria. , 1995, The Journal of pediatrics.

[6]  S. Daviss,et al.  Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons , 1995, Psychiatry Research.

[7]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[8]  L. Paterson,et al.  Neuropsychological effects of subsequent exposure to phenylalanine in adolescents and young adults with early-treated phenylketonuria. , 1995, Journal of intellectual disability research : JIDR.

[9]  M. Fernstrom,et al.  Acute tyrosine depletion reduces tyrosine hydroxylation rate in rat central nervous system. , 1995, Life sciences.

[10]  E. G. Jones,et al.  Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.

[11]  P. Goldman-Rakic.  Cellular basis of working memory , 1995, Neuron.

[12]  F. Benes.  Is There a Neuroanatomic Basis for Schizophrenia? An Old Question Revisited , 1995 .

[13]  M. Fernstrom,et al.  Effect of chronic protein ingestion on rat central nervous system tyrosine levels and in vivo tyrosine hydroxylation rate , 1995, Brain Research.

[14]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[15]  L. Sonneville,et al.  Review of neuropsychological functioning in treated phenylketonuria: an information processing approach , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[16]  H. Lou.  Dopamine precursors and brain function in phenylalanine hydroxylase deficiency , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[17]  A. Diamond,et al.  Phenylalanine levels of 6‐10mg/dl may not be as benign as once thought , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[18]  A. Diamond,et al.  An animal model of early-treated PKU , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  J. Schrot,et al.  Tyrosine reverses a cold-induced working memory deficit in humans , 1994, Pharmacology Biochemistry and Behavior.

[20]  S. Deutsch,et al.  L-tyrosine pharmacotherapy of schizophrenia: preliminary data. , 1994, Clinical neuropharmacology.

[21]  J. McDonald,et al.  Mouse models of human phenylketonuria. , 1993, Genetics.

[22]  P. Kalivas.  Neurotransmitter regulation of dopamine neurons in the ventral tegmental area , 1993, Brain Research Reviews.

[23]  M. Mazzocco,et al.  Cognition and tyrosine supplementation among school-aged children with phenylketonuria. , 1992, American journal of diseases of children.

[24]  R E Litman,et al.  Correlation of Wisconsin Card Sorting Test performance with eye tracking in schizophrenia. , 1991, The American journal of psychiatry.

[25]  R. Roth,et al.  The Anxiogenic β‐Carboline FG 7142 Selectively Increases Dopamine Release in Rat Prefrontal Cortex as Measured by Microdialysis , 1991, Journal of neurochemistry.

[26]  B. Berger,et al.  Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates , 1991, Trends in Neurosciences.

[27]  B. Pennington,et al.  Neuropsychology of early-treated phenylketonuria: specific executive function deficits. , 1990, Child development.

[28]  I. Bodis-Wollner.  Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients , 1990, Trends in Neurosciences.

[29]  R. Roth,et al.  Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization. , 1990, The Journal of pharmacology and experimental therapeutics.

[30]  Harris R. Lieberman,et al.  Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans , 1989, Brain Research Bulletin.

[31]  R. Roth,et al.  Stress and the Mesocorticolimbic Dopamine Systems a , 1988, Annals of the New York Academy of Sciences.

[32]  D. Levy,et al.  A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. , 1988, Archives of general psychiatry.

[33]  R. Wurtman,et al.  Effects of systemicl-tyrosine on dopamine release from rat corpus striatum and nucleus accumbens , 1988, Brain Research.

[34]  A. Gerdes,et al.  Increased Vigilance and Dopamine Synthesis by Large Doses of Tyrosine or Phenylalanine Restriction in Phenylketonuria , 1987, Acta paediatrica Scandinavica.

[35]  D. Faust,et al.  Neuropsychological Functioning in Treated Phenylketonuria , 1987, International journal of psychiatry in medicine.

[36]  M. Fernstrom,et al.  Effect of tyrosine administration on dopa accumulation in light- and dark-adapted retinas from normal and diabetic rats. , 1986, Life sciences.

[37]  A. Dunn,et al.  Tyrosine Hydroxylase Activation in Mesocortical 3,4‐Dihydroxyphenylethylamine Neurons Following Footshock , 1986, Journal of neurochemistry.

[38]  J D Milner,et al.  Catecholamine synthesis: physiological coupling to precursor supply. , 1986, Biochemical pharmacology.

[39]  R. Roth,et al.  Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. , 1986, The Journal of pharmacology and experimental therapeutics.

[40]  R. Roth,et al.  Selective increase in dopamine metabolism in the prefrontal cortex by the anxiogenic beta-carboline FG 7142. , 1985, Biochemical pharmacology.

[41]  B. Pennington,et al.  Neuropsychological deficits in early treated phenylketonuric children. , 1985, American journal of mental deficiency.

[42]  R. Roth,et al.  Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons , 1984, Neuroscience.

[43]  J. Fernstrom.  Role of precursor availability in control of monoamine biosynthesis in brain. , 1983, Physiological reviews.

[44]  A. Badawy,et al.  Enhancement of rat brain catecholamine synthesis by administration of small doses of tyrosine and evidence for substrate inhibition of tyrosine hydroxylase activity by large doses of the amino acid. , 1982, The Biochemical journal.

[45]  R. Wurtman,et al.  Precursor control of neurotransmitter synthesis. , 1980, Pharmacological reviews.

[46]  R. A. MacCready,et al.  Admissions of phenylketonuric patients to residential institutions before and after screening programs of the newborn infant. , 1974, The Journal of pediatrics.

[47]  K. Neve,et al.  Dopamine Receptors , 2008 .

[48]  F. J. White,et al.  Synaptic regulation of mesocorticolimbic dopamine neurons. , 1996, Annual review of neuroscience.

[49]  R. Roth,et al.  The role of mesoprefrontal dopamine neurons in stress. , 1996, Critical reviews in neurobiology.

[50]  N. Mendell,et al.  Eye tracking and schizophrenia: a selective review. , 1994, Schizophrenia bulletin.

[51]  Bruce F. Pennington,et al.  A normative‐developmental study of executive function: A window on prefrontal function in children , 1991 .

[52]  R. Roth,et al.  The determinants of stress-induced activation of the prefrontal cortical dopamine system. , 1990, Progress in brain research.

[53]  I. Smith.  8 – The hyperphenylalaninaemias , 1985 .

[54]  S. Levin,et al.  Frontal lobe dysfunctions in schizophrenia--I. Eye movement impairments. , 1984, Journal of psychiatric research.